Syra Health Corp. Class A (SYRA)
OTHER OTC:SYRA
Want to see SYRA full AI Analyst Report?
SYRA Stock Chart & Stats
$0.09
-$0.12(-16.06%)
At close: 4:00 PM EST
$0.09
-$0.12(-16.06%)
Day’s Range― - ―
52-Week Range$0.05 - $0.70
Previous CloseN/A
Volume2.20M
Average Volume (3M)9.76K
Market Cap
$6.21M
Enterprise Value$4.43M
Total Cash (Recent Filing)$1.61M
Total Debt (Recent Filing)$143.79K
Price to Earnings (P/E)―
Beta1.08
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding11,339,169
10 Day Avg. Volume11,249
30 Day Avg. Volume9,759
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.49
Price to Sales (P/S)0.14
P/FCF Ratio-2.28
Enterprise Value/Market Cap0.71
Enterprise Value/Revenue0.61
Enterprise Value/Gross Profit2.05
Enterprise Value/Ebitda-5.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Gross Margin ExpansionA material expansion in gross margin implies improving unit economics and better cost structure for service delivery. Sustained higher gross margins strengthen path to operating profitability, increase resilience to pricing pressure, and provide more cash per dollar of revenue to reinvest in growth.
Sharply Reduced Cash BurnDramatic reduction in operating cash burn indicates improved cash discipline, tighter working capital management, or more efficient operations. This materially extends runway, lowers near-term financing pressure, and increases the probability of reaching sustainable cash generation if the trend continues.
Low Leverage And Smaller Debt LoadA conservative debt profile provides flexibility for a services business dependent on contract timing. Low leverage reduces interest burden and bankruptcy risk, supports bidding on government contracts, and preserves capacity to raise capital on reasonable terms while executing margin and cash-flow improvements.
Bears Say
Persistent Net LossesOngoing annual net losses erode equity and limit the company's ability to self-fund growth. Even with margin improvement, sustained profitability is required to remove reliance on external financing, support investment in capabilities, and validate the business model over the medium term.
Revenue Decline In 2025 Vs 2024A year-over-year revenue decline interrupts the revenue scaling narrative and undermines operating leverage. For a contracting services firm, slower or volatile revenue raises concerns about client retention, contract renewals, or demand sustainability, making margin gains harder to translate to durable profit.
Negative Operating Cash Flow Still PresentPersistent negative operating and free cash flow means the business continues to require external funding or equity dilution to sustain operations. Until operating cash flow consistently turns positive, liquidity constraints may limit hiring, bidding on larger contracts, and investment in growth initiatives.
Syra Health Corp. Class A News
SYRA FAQ
What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.05 and its highest was $0.70 in the past 12 months.
What is Syra Health Corp. Class A’s market cap?
Syra Health Corp. Class A’s market cap is $6.21M.
When is Syra Health Corp. Class A’s upcoming earnings report date?
Syra Health Corp. Class A’s upcoming earnings report date is May 07, 2026 which is in 7 days.
How were Syra Health Corp. Class A’s earnings last quarter?
Syra Health Corp. Class A released its earnings results on Mar 12, 2026. The company reported -$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.011.
Is Syra Health Corp. Class A overvalued?
According to Wall Street analysts Syra Health Corp. Class A’s price is currently Overvalued.
Does Syra Health Corp. Class A pay dividends?
Syra Health Corp. Class A does not currently pay dividends.
What is Syra Health Corp. Class A’s EPS estimate?
Syra Health Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syra Health Corp. Class A have?
Syra Health Corp. Class A has 11,339,169 shares outstanding.
What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
Syra Health Corp. Class A reported an EPS of -$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of Syra Health Corp. Class A?
Currently, no hedge funds are holding shares in SYRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syra Health Corp. Class A
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
―
Cryo-Cell International
―
P3 Health Partners
―
Ownership Overview
Options Prices
Currently, No data available
---